Improved growth and decreased morbidities in <1000 g neonates after early management changes

Area of Science:

• Neonatalogy
• Pediatric Growth and Development
• Critical Care Medicine

Background:

• Extra-uterine growth restriction (EUGR) is a significant concern for extremely low birth weight (ELBW) neonates, impacting long-term outcomes.
• Optimizing early management strategies is crucial for improving growth and reducing morbidity in this vulnerable population.

Purpose of the Study:

• To evaluate the impact of three specific early management practice changes (EMPC) on reducing EUGR in ELBW neonates.
• To assess the feasibility, safety, and effectiveness of these interventions.

Main Methods:

• A historical cohort study compared ELBW infants (<=1000 g birth weight) before (n=87) and after (n=76) the implementation of EMPC.
• EMPC included surfactant at delivery with immediate extubation to nasal CPAP, decreased oxygen exposure, and early parenteral amino acids.
• Outcomes included feeding, growth parameters, morbidities, and interventions, analyzed using chi-squared tests, Student's t-tests, and ANOVA.

Main Results:

• Infants in the post-EMPC cohort demonstrated faster birth weight regain and maintained appropriate size for gestational age at 36 weeks.
• The post-EMPC group experienced less morbidity associated with poor long-term outcomes.
• Lower birth weight (<750 g) and surgical necrotizing enterocolitis were identified as predictors of EUGR.

Conclusions:

• The introduction of surfactant, immediate extubation to CPAP, reduced oxygen exposure, and early parenteral amino acids is feasible and safe for ELBW infants.
• These early management practice changes are associated with significant improvements in infant growth and a reduction in morbidity.
• The study supports the adoption of these interventions to enhance neonatal outcomes in ELBW populations.